NULL is a synthetic progestogen that is structurally similar to natural progesterone. It is highly effective when taken orally and acts directly on the endometrium (lining of the uterus), causing it to transform into a secretory state. Unlike some other progestogens, NULL does not exhibit androgenic, estrogenic, glucocorticoid, or mineralocorticoid activity, leading to a favourable side effect profile. It is primarily used to treat various conditions resulting from a deficiency of endogenous progesterone.

NULL is a retroprogesterone derivative, meaning its chemical structure is slightly modified from natural progesterone, making it highly bioavailable and orally active. The 10mg dose is standard for achieving endometrial transformation and is used in various therapeutic regimens.

The principal action of NULL is to prepare the uterine lining for potential pregnancy or to regulate the menstrual cycle. In Hormone Replacement Therapy (HRT), it is vital for protecting the endometrium from the proliferative effects of unopposed estrogen, thereby reducing the risk of endometrial hyperplasia and cancer.

In conditions like threatened or habitual abortion, NULL helps sustain pregnancy by supporting the luteal phase and maintaining a healthy uterine environment. Its high selectivity for the progesterone receptor and lack of interaction with other steroid receptors make it a targeted and well-tolerated treatment option in gynaecological practice.

NULL is indicated for the treatment of various progesterone deficiency states, including:

Hormone Replacement Therapy (HRT):

To counteract the effects of estrogen on the endometrium in women with an intact uterus.

Dysfunctional Uterine Bleeding (DUB):

To control and regulate heavy or irregular bleeding.

Dysmenorrhea (Painful Menstruation):

To relieve pain associated with menstruation.

Endometriosis:

Used to suppress the growth and activity of endometrial tissue outside the uterus.

Threatened and Habitual Abortion (Recurrent Miscarriage):

To support the luteal phase and reduce the risk of miscarriage in cases of proven progesterone deficiency.

Secondary Amenorrhea:

To induce menstruation in women who have stopped having periods for reasons other than pregnancy.

Endometrial Protection:

In HRT, it protects the uterine lining from potential overgrowth caused by estrogen.

Cycle Regulation:

Effectively manages abnormal uterine bleeding and regulates menstrual cycles.

Pregnancy Support:

Helps maintain pregnancy in women with a history of recurrent miscarriage linked to progesterone insufficiency.

High Specificity:

Minimal interaction with non-progesterone receptors, resulting in fewer unwanted side effects like fluid retention or changes in blood pressure, compared to some other synthetic progestogens.

Side effects associated with NULL are usually mild and temporary.

Common Side Effects:

• Headache

• Migraine

• Nausea or stomach discomfort

• Breast tenderness or pain

• Changes in menstrual bleeding patterns (e.g., breakthrough bleeding or spotting).

Serious Side Effects (Consult your doctor immediately if you experience):

• Signs of Liver Dysfunction: Yellowing of the skin or eyes (jaundice), severe pain in the upper abdomen, or unusual dark urine.

• Symptoms of a Blood Clot (Thromboembolism): Swelling, severe pain, or redness in a leg (Deep Vein Thrombosis - DVT), or sudden shortness of breath and chest pain (Pulmonary Embolism - PE).

• Severe Allergic Reaction: Swelling of the face, lips, tongue, or throat, which may cause breathing difficulty.

• Dosage: NULL 10mg is typically taken once or twice daily, depending on the condition being treated. The dosage regimen (start and stop dates) is highly specific and must be determined by a healthcare professional.
• Administration: Swallow the tablet whole with a glass of water. It can be taken with or without food.
• Regimen Compliance: It is crucial to strictly follow the dosing schedule provided by your doctor, especially when used for cycle regulation or HRT. Taking the drug on the wrong days can lead to irregular bleeding.

NULL is a powerful progestogen that acts by binding selectively to progesterone receptors (PRs) located in the target organs, particularly the endometrium.

1. Receptor Activation: Once absorbed and circulated, NULL binds to and activates the progesterone receptors in the uterine lining.
2. Secretory Transformation: This activation induces a full secretory transformation of the endometrium that has been pre-primed by estrogen. This action prepares the lining for the implantation of a fertilised egg.
3. Anti-Proliferative Effect (in HRT): When used with estrogen in HRT, this transformation counters the estrogen-induced proliferation, ensuring the shedding of the uterine lining (a period-like bleed) and preventing endometrial overgrowth.
4. Pregnancy Maintenance: In the context of pregnancy support, NULL ensures adequate progesterone levels to maintain the decidual layer and reduce uterine contractility.

• Follow the Schedule: For gynaecological conditions, the timing and duration of treatment are critical. Always take the tablets exactly as prescribed for the specific days of your cycle.

• Irregular Bleeding: Breakthrough bleeding or spotting may occur, especially during the first few months of use. If this persists or becomes heavy, consult your doctor.

• Regular Check-ups: If you are using NULL as part of HRT, regular gynaecological check-ups, including breast exams and cervical screenings, are necessary.

• Pregnancy Use: Only use for pregnancy support if specifically prescribed and monitored by a fertility specialist or obstetrician.

• Store at room temperature (below 30°C or 86°F).

• Keep the tablets in the original packaging to protect them from moisture and light.

• Keep out of reach of children.

• Grapefruit Juice: No known significant interaction.

• General Diet: No specific dietary restrictions are require

• Enzyme Inducers (e.g., Phenytoin, Phenobarbital, Carbamazepine, Rifampicin): These drugs speed up the metabolism of NULL in the liver, which may reduce its effectiveness. A higher dose of NULL might be required.

• Herbal Products (e.g., St. John's Wort): Can also induce liver enzymes and decrease the efficacy of NULL.

• Ritonavir, Nelfinavir (HIV medications): Although known as enzyme inhibitors, they can also act as inducers and reduce progestogen levels.

• Undiagnosed Vaginal Bleeding: Should not be used until the cause of the bleeding is fully investigated by a doctor.

• Known or Suspected Sex Hormone-Dependent Malignancies (e.g., Breast Cancer): CONTRAINDICATED.

• Severe Liver Disease: CONTRAINDICATED.

• Thromboembolic Disorders (Blood Clots): Caution is needed; patients should be monitored closely.

The daily dose is typically 10mg, but the number of tablets and the total daily dose depend entirely on the specific indication (e.g., for HRT vs. miscarriage prevention). Treatment may involve taking 10mg once or twice daily for a set number of days each month.

NULL has a very low toxicity profile, even in high doses. No specific antidote exists. Action Required: Overdose usually results only in symptoms like nausea, vomiting, dizziness, or breast tenderness. Seek medical advice for supportive treatment if a very large quantity is consumed.

If you forget to take a tablet, take it as soon as you remember, unless more than 12 hours have passed since the scheduled time. If it has been more than 12 hours, skip the missed dose and take the next one at the usual time. Do not take a double dose to make up for a forgotten tablet.